Malaria in Austria 1990-2000.
In Austria, between 1990 and 2000, 924 travel related malaria cases were reported (mean = 84/year). No significant decreasing or increasing trends were observed. P. falciparum (n=517; 55.9%) accounted for the highest number of cases followed by P. vivax or ovale (n=321; 34.7%) and P. malariae (n=29; 2.2%). Most infections were contracted in highly endemic malaria regions (n=686; 74.2%) and most cases were reported from the largest counties: Vienna (n=336, 36.4%), Styria (n=156, 16.8%), and Lower Austria (n=151, 16.3%). Overall, 12 deaths occurred, most were caused by P. falciparum (n=9, 75%; case fatality rate: 1.9%). Data on chemoprophylaxis was available for 752 cases (81.4%) but only half of them (n=367, 48.8%) gave detailed information on the drug used. Data on compliance were obtained for only 45.4% of the cases, with only about 60% of patients completing the full course of prophylaxis.
Strauss
R
R
Federal Ministry for Social Security and Generations, Section Public Health, Vienna, Austria.
Pfeifer
C
C
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000818:Animals; D001317:Austria / Q000453:epidemiology; D018890:Chemoprevention / Q000379:methods / Q000706:statistics & numerical data; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use; D018563:Disease Notification / Q000379:methods; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D016780:Malaria, Vivax / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D010349:Patient Compliance / Q000706:statistics & numerical data; D010963:Plasmodium falciparum / Q000187:drug effects / Q000302:isolation & purification; D010965:Plasmodium malariae / Q000187:drug effects / Q000302:isolation & purification; D010966:Plasmodium vivax / Q000187:drug effects / Q000302:isolation & purification; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D017678:Sex Distribution; D013413:Sulfadoxine / Q000627:therapeutic use
D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D002727:Proguanil; D015767:Mefloquine; D011739:Pyrimethamine